Corpus overview


MeSH Disease

HGNC Genes

SARS-CoV-2 proteins

There are no SARS-CoV-2 protein terms in the subcorpus


SARS-CoV-2 Proteins
    displaying 1 - 1 records in total 1
    records per page

    Deep RNA Sequencing of Intensive Care Unit Patients with COVID-19 MESHD

    Authors: Sean F Monaghan; Alger M Fredericks; Maximilian S Jentzsch; William G Cioffi; Maya Cohen; William G Fairbrother; Shivam J Gandhi; Elizabeth O Harrington; Gerard J Nau; Jonathan S Reichner; Corey E Ventetuolo; Mitchell M Levy; Alfred Ayala

    doi:10.1101/2021.01.11.21249276 Date: 2021-01-13 Source: medRxiv

    Purpose COVID-19 MESHD has impacted millions of patients across the world. Molecular testing occurring now identifies the presence of the virus at the sampling site: nasopharynx, nares, or oral cavity. RNA sequencing has the potential to establish both the presence of the virus and define the hosts response in COVID-19 MESHD. MethodsSingle center, prospective study of patients with COVID-19 MESHD admitted to the intensive care unit where deep RNA sequencing (>100 million reads) of peripheral blood with computational biology analysis was done. All patients had positive SARS-CoV-2 PCR. Clinical data was prospectively collected. ResultsWe enrolled fifteen patients at a single hospital. Patients were critically ill with a mortality of 47% and 67% were on a ventilator. All the patients had the SARS-CoV- MESHD2 RNA identified in the blood in addition to RNA from other viruses, bacteria, and archaea. The expression of many immune modulating genes, including PD-L1 HGNC and PD-L2 HGNC, were significantly different in patients who died from COVID-19 MESHD. Some proteins were influenced by alternative transcription and splicing events, as seen in HLA-C, HLA-E HGNC, NRP1 HGNC and NRP2 HGNC. Entropy calculated from alternative RNA splicing and transcription start/end predicted mortality in these patients. ConclusionsCurrent upper respiratory tract testing for COVID-19 MESHD only determines if the virus is present. Deep RNA sequencing with appropriate computational biology may provide important prognostic information and point to therapeutic foci to be precisely targeted in future studies. Take Home MessageDeep RNA sequencing provides a novel diagnostic tool for critically ill MESHD patients. Among ICU patients with COVID-19 MESHD, RNA sequencings can identify gene expression, pathogens (including SARS-CoV-2), and can predict mortality. TweetDeep RNA sequencing is a novel technology that can assist in the care of critically ill COVID-19 MESHD patients & can be applied to other disease

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
HGNC Genes
SARS-CoV-2 Proteins

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.